Ken Griffin’s 2seventy bio TSVT Stock Holding History

Ken Griffin’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-12,318	Closed	-$39.1K	–	15592
2024 Q4	$36.2K	Buy	12,318 +12,201	+10,428%	+$50K	﹤0.01%	12703
2024 Q3	$552	Sell	117 -18,887	-99%	-$85.2K	﹤0.01%	13998
2024 Q2	$73.2K	Sell	19,004 -29,514	-61%	-$133K	﹤0.01%	11321
2024 Q1	$260K	Sell	48,518 -93,371	-66%	-$439K	﹤0.01%	9780
2023 Q4	$606K	Sell	141,889 -240,337	-63%	-$739K	﹤0.01%	7681
2023 Q3	$1.5M	Buy	382,226 +178,117	+87%	+$1.17M	﹤0.01%	5763
2023 Q2	$2.07M	Sell	204,109 -2,162,130	-91%	-$22.9M	﹤0.01%	5093
2023 Q1	$24.1M	Buy	2,366,239 +2,104,527	+804%	+$24.1M	0.01%	1738
2022 Q4	$2.45M	Buy	261,712 +146,054	+126%	+$2.06M	﹤0.01%	5107
2022 Q3	$1.68M	Buy	115,658 +15,168	+15%	+$225K	﹤0.01%	5923
2022 Q2	$1.33M	Buy	+100,490	New	+$1.37M	﹤0.01%	6393

Other funds holding TSVT

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Ken Griffin's TSVT Position: Q1 2025 in Review

Ken Griffin sold out of 2seventy bio (TSVT) in Q1 2025, closing a stake of 12,318 shares — an estimated $39.1K sold.

Ken Griffin first reported a position in TSVT in Q2 2022 and held it in 11 quarters. The position peaked at $24.1M in Q1 2023. 139 funds tracked by Wall St. Rank hold TSVT as of Q1 2025.

Ken Griffin reported no remaining 2seventy bio position as of Q1 2025 after selling out during the quarter.
Ken Griffin sold 12,318 2seventy bio shares in Q1 2025, an estimated $39.1K.
Ken Griffin first reported a position in 2seventy bio in Q2 2022 and held it in 11 quarters.
Ken Griffin's 2seventy bio position peaked at $24.1M in Q1 2023.
139 funds tracked by Wall St. Rank held 2seventy bio as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.